Healthcare Contract Manufacturing Market 9.86% CAGR Expected To Boost by Sterile and Non-Sterile Type, Service, Industry Analysis and Forecasts 2023

Healthcare Contract Manufacturing Market
The Global Healthcare Contract Manufacturing Market is expected to grow at a CAGR of 9.86% during the forecast period 2017–2023. Market Research Future has a cooked research report on the Global Healthcare Contract Manufacturing Industry.

The Worldwide Healthcare Contract Manufacturing Market is majorly driven by factors such as patent protection expiration of major drugs and medical devices, and competition and economics of production and trade to favor CMO will boost the market growth.

The Global Healthcare Contract Manufacturing Market is expected to grow due to the increasing demand for drugs and medical devices because of the growing population, especially in emerging economies. The market around the globe is expanding especially in developing countries such as India and China. There is a major patent cliff occurring in the healthcare market worldwide, more specifically in the pharmaceutical industry.

The patent cliff will result in cheaper generic versions in the market which in turn will increase the demand for CROs. The increased demand is expected to benefit the healthcare contract manufacturing industry. Due to patent expirations, it is assumed that the drug sales will face a loss of approximately 75 USD billion between 2016 and 2023. Roughly the drug sales of 60 USD billion of is expected to be threatened by generics. The off-patent drugs in 2016 were adalimumab, ledipasvir/sofosbuvir, rituximab, bevacizumab, and trastuzumab. Thus, patent protection expiration of major drugs and the growing demand for generic drugs are likely to boost the growth of CMOs globally.

Get Exclusive Sample Report @ https://www.marketresearchfuture.com/sample_request/5637 .

The increasing demand for personalization and customization of healthcare has created the demand for smart medical devices. This has created a need for real-time monitoring devices which will fuel the demand for advanced medical devices. Thus, increasing customization and personalization will drive the global healthcare contract manufacturing market in the future.

Global Healthcare Contract Manufacturing Market Segmentation:

The Global Healthcare Contract Manufacturing Market is segmented on the basis of type, service type, and industry. On the basis the type, it is segmented into sterile and non-sterile. On the basis of the service type, it is segmented into pharmaceutical contract manufacturing services, medical device contract manufacturing services. On the basis of the industry, it is segmented into pharmaceutical, medical device and biopharmaceutical.

Worldwide Healthcare Contract Manufacturing Market Key Players:

Some of key the players in the global healthcare contract manufacturings market are Patheon (Netherlands), Lonza (Switzerland), Evonik Industries (Germany), Teva Pharmaceutical Industries (Israel), Boehringer Ingelheim BioXcellence (Germany), Famar S.A. (Greece), Fareva Group (France), Vetter Pharma International (Germany), Mylan (U.S.), Recipharm (Sweden), Aesica Pharmaceuticals (U.K.), Althea Technologies (U.S.),  Aenova (Germany), Dishman Pharmaceuticals and Chemicals Limited (India), Catalent Pharma Solutions (U.S.), Kemwell Pvt. Ltd. (India), Jubilant Life Sciences Limited (India), Nipro Corporation (Japan), NextPharma (UK), Pfizer Central Source (U.S.), Royal DSM N.V. (Netherlands), Abbott Laboratories (U.S.), Amgen (U.S.), Apotex (U.S.), Aspen (U.S.), AstraZeneca PLC (UK), Aurobindo Pharma (India), Baxter International  (U.S.), BERLIN-CHEMIE (Germany), Biocon (India), Biogen (U.S.), Celltrion (South Korea),  Cipla (India), Coherus Biosciences (U.S.), Daiichi Sankyo (Japan), Dr. Reddy’s Laboratories (India), Eli Lilly and Company (U.S.), Emcure Pharmaceuticals (India), Eurofarma Laboratories (Brazil), Gedeon Richter (Hungary), Gilead Sciences (U.S.), GlaxoSmithKline (GSK) Plc (U.S.), Hospira (U.S.), Impax Laboratories (U.S.), Intas Pharmaceuticals (India), Janssen Pharmaceuticals (U.S.), Lupin (India), Merck and Co. Inc. (U.S.), Mitsubishi Tanabe Pharma (Japan), Momenta Pharmaceuticals (U.S.), Natco Pharma (India), Nexus Pharmaceuticals (U.S.), Novo Nordisk (Denmark), Orchid Chemicals & Pharmaceuticals (India), Par Pharmaceutical (U.S.), Parenteral Drugs (India), Piramal (India), Roche Holding (Switerzland), Sanofi (France), Synthon (Netherlands), Teva Pharmaceuticals (Israel), Valeant Pharmaceuticals (Canada), Zentiva (Czech Republic), Zhejiang Huahai Pharmaceutical (China), Zydus Cadila (India) and others.

Get Discount @ https://www.marketresearchfuture.com/check-discount/5637 .

Healthcare Contract Manufacturing Market Regional Analysis:

Global Healthcare Contract Manufacturing consist of regions namely the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas holds the largest share of the global healthcare contract manufacturing market owing to the rising number of drug approvals as one of the factors fuelling the growth. The patent expiries of blockbuster drugs are creating a new opportunity to vendors to develop Biosimilars at low cost. Thus, the market is anticipated entry of biosimilars and generics, which is likely to further strengthen the growth in this region.

The European market dominated the global healthcare contract manufacturings market owing to the high prevalence rate of various disease in the Eastern European regions.

The Asia Pacific region is anticipated to be the fastest growing region over the forecast period owing to the increasingly favorable government initiatives along with the improving healthcare infrastructure.

Major Table of Contents for Healthcare Contract Manufacturing Market:

1 Introduction

1.1 Definition

1.2 Scope of Study

1.3 Research Objective

1.4 Assumptions & Limitations

1.5 Market Structure

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3 Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

3.5 Macroeconomic Indicators

4 Market Factor Analysis

4.1 Porter’s five forces model

4.1.1 Bargaining Power of suppliers

4.1.2 Bargaining Power of Customer

TOC Continued….!

Demand Your Customized Report with Competitive Analysis of Niche Segments, Top Players, Comprehensive Research and Key Regions @ https://www.marketresearchfuture.com/enquiry/5637 .

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/check-discount/5637